These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23551682)

  • 21. Renin-angiotensin-aldosterone system in patients on maintenance hemodialysis.
    Ivić M; Strahinjić S; Stefanović V
    Acta Med Iugosl; 1987; 41(3):205-13. PubMed ID: 3661237
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.
    Morishita Y; Hanawa S; Chinda J; Iimura O; Tsunematsu S; Kusano E
    Hypertens Res; 2011 Mar; 34(3):308-13. PubMed ID: 21124333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
    Hirsch S
    Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of RAAS inhibition in patients on peritoneal dialysis.
    Guest S
    Nephrol News Issues; 2012 May; 26(6):42-5. PubMed ID: 22690459
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blocking the renin-angiotensin system in chronic kidney disease].
    Segura J
    Nefrologia; 2004; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
    [No Abstract]   [Full Text] [Related]  

  • 26. Requirement of drug development for chronic renal disease: Other strategies than blockade of the renin-angiotensin system.
    Okamoto T
    Int J Mol Med; 2003 May; 11(5):651-4. PubMed ID: 12684706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of the acute antihypertensive effect of captopril in patients on hemodialysis].
    Ishimitsu T; Yamakado M; Tagawa H
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):447-54. PubMed ID: 3528597
    [No Abstract]   [Full Text] [Related]  

  • 29. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
    Shen JI; Saxena AB; Vangala S; Dhaliwal SK; Winkelmayer WC
    BMC Nephrol; 2017 Jun; 18(1):196. PubMed ID: 28623899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plasma renin level and therapy in renal hypertension].
    Diekmann L; Bonzel KE; Jenett WD; Michelis K; Wagner H
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):373-5. PubMed ID: 876171
    [No Abstract]   [Full Text] [Related]  

  • 31. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kidney concentrating function in renal denervation and pharmacological effects].
    Pirŭova B
    Eksp Med Morfol; 1988; 27(2):50-5. PubMed ID: 3168909
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibitor and anemia in a patient undergoing hemodialysis.
    Yoshida A; Morozumi K; Suganuma T; Aoki J; Sugito K; Nakamura S; Ikeda M; Oikawa T; Fujinami T; Kawahara H
    Nephron; 1991; 59(2):334-5. PubMed ID: 1956504
    [No Abstract]   [Full Text] [Related]  

  • 34. Antihypertensive therapy with aliskiren.
    Luft FC; Weinberger MH
    Kidney Int; 2008 Mar; 73(6):679-83. PubMed ID: 18160962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
    Griffin KA; Bidani AK
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular remodeling of the renin-angiotensin system after kidney transplantation.
    Antlanger M; Domenig O; Kovarik JJ; Kaltenecker CC; Kopecky C; Poglitsch M; Säemann MD
    J Renin Angiotensin Aldosterone Syst; 2017; 18(2):1470320317705232. PubMed ID: 28490223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.
    Lambers Heerspink HJ; Perkovic V; de Zeeuw D
    J Hypertens; 2009 Dec; 27(12):2321-31. PubMed ID: 19727007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension in children with end-stage renal disease.
    Roszkowska-Blaim M; Skrzypczyk P
    Adv Med Sci; 2015 Sep; 60(2):342-8. PubMed ID: 26275711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future.
    Mackenzie HS; Ziai F; Omer SA; Nadim MK; Taal MW
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S283-6. PubMed ID: 10201884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.